For instance, The Cancer Genome Atlas (TCGA) published a melanoma study involving 331 melanoma patients, describing the landscape of somatic alterations in CMs and identifying multiple significant driver genes, including BRAF, NRAS, TP53, NF1, and CDKN2A12. This evidence concerns the gene TP53 and melanoma.